You are here

Article Text

Article menu
Download PDFPDF
PostScript
Letter
Comment on impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test
  1. Richard F Logan1,2,
  2. Stephen P Halloran3
  1. 1 Eastern Hub, Bowel Cancer Screening Programme, Nottingham University Hospitals Nottingham, Nottingham, UK
  2. 2 Epidemiology and Public Health, University of Nottingham, Nottingham, UK
  3. 3 Southern Hub, Bowel Cancer Screening Programme, University of Surrey, Guildford, UK
  1. Correspondence to Professor Richard F Logan, Eastern Hub, Bowel Cancer Screening Programme, Nottingham University Hospitals Nottingham, Nottingham NG7 2UH, UK; richard.logan{at}nottingham.ac.uk

https://doi.org/10.1136/gutjnl-2014-308902

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Sir,

    Zorzi et al 1 are to be commended for their timely analysis of the impact of using a faecal immunochemical test (FIT) on colorectal cancer mortality in their screening programme. The 24% colorectal cancer mortality reduction they report will surely give impetus to efforts to introduce FIT into other screening programmes. As they rightly observe, the impact of these newer screening tests is likely only to be determined from observational studies such as their study rather than further randomised trials.

    Nevertheless, some …

    View Full Text

    Footnotes

    • Contributors RFL and SPH both contributed to the drafting of this letter.

    • Competing interests None.

    • Provenance and peer review Not commissioned; internally peer reviewed.

    Linked Articles